Profil
Jeffrey Otto has been Director of Genetic Services for SEQUENOM, Inc. since joining the company on November 29, 2005.
He was Director of Business Development for Genaissance Pharmaceuticals, Inc. from 2000 to 2005.
From 1995 to 2000, Dr. Otto was Principal Investigator of the Rush-Presbyterian Department of Orthopedic Surgery for the St. Luke's Medical Center.
He received an MBA from Ellis College of the New York Institute of Technology, a PhD from Marquette University and a BA from Carthage College.
Anciens postes connus de Jeffrey Otto
| Sociétés | Poste | Fin |
|---|---|---|
Genaissance Pharmaceuticals, Inc.
 Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Corporate Officer/Principal | 01/01/2005 |
| SEQUENOM, INC. | Corporate Officer/Principal | - |
Formation de Jeffrey Otto
| New York Institute of Technology | Masters Business Admin |
| Marquette University | Doctorate Degree |
| Carthage College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Sequenom, Inc.
 Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
Genaissance Pharmaceuticals, Inc.
Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Health Technology |
